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ABSTRACT
Objective: Slowing and frontal spread of the alpha rhythm have been reported in multiple epilepsy syndromes. We 
investigated whether these phenomena are associated with seizure control.
Methods: We prospectively acquired resting-state EEG in 63 patients with focal and idiopathic generalized epilepsy (FE 
and IGE) and 39 age- and gender-matched healthy subjects. Patients were divided into good and poor (≥ 4 seizures / 12 
months) seizure control groups based on self-reports and clinical records. We computed spectral power from 20-second 
EEG segments during eyes-closed wakefulness, free of interictal abnormalities, and quantified power in high and low 
alpha bands. Analysis of covariance and post-hoc t-tests were used to assess group differences in alpha-power shift 
across all EEG channels. Permutation-based statistics were used to assess the topography of this shift across the whole 
scalp.
Results: Compared to healthy subjects, patients showed a statistically significant shift of spectral power from high- to 
low-alpha frequencies (effect size g = 0.78 [95% confidence interval 0.43,1.20]). This alpha-power shift was driven by 
patients with poor seizure control in both FE and IGE (g = 1.14, [0.65,1.74]), and occurred over midline frontal and 
bilateral occipital regions. IGE exhibited less alpha power shift compared to FE over bilateral frontal regions (g = -1.16 
[-0.68, -1.74]). There was no interaction between syndrome and seizure control. Effects were independent of 
antiepileptic drug load, time of day, or subgroup definitions.
Interpretation: Alpha slowing and anteriorisation are a robust finding in patients with epilepsy and might represent a 
generic indicator of seizure liability.
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INTRODUCTION 
The human alpha rhythm is a prominent oscillatory electroencephalographic signal seen over occipital recording sites 
during relaxed, eyes-closed wakefulness. It is thought to arise through cortico-thalamic interactions, and to possibly 
reflect top-down processes that subtend a vast number of cognitive operations, in particular attention and working 
memory1. The importance of the alpha rhythm is underscored by its alterations in neurological disease, where it typically 
slows down and loses its characteristic anterior-to-posterior gradient - changes that are usually commensurate with 
clinical severity and therefore useful to monitor neurological dysfunction2. 
These alterations of alpha, which are often seen over longer stretches of the electroencephalogram (EEG), are 
considered to be the hallmark of diffuse cortical-subcortical neuropathology, such as metabolic or neurodegenerative 
diseases, but they have been found in epilepsy as well. In fact, studies conducted during the first decades of EEG 
research found conspicuous alpha rhythm alterations in epilepsy patients; specifically, they reported that both power and  
topography of the alpha rhythm were shifted: power from higher (8-13 Hz) to lower (6-9 Hz) frequencies, and 
topography from occipital to frontal sites3,4. Subsequent quantitative EEG studies confirmed these alterations in a wide 
variety of focal epilepsy (FE) and idiopathic (or genetic) generalized epilepsy (IGE) syndromes, and have identified 
them in unaffected first-degree IGE relatives and in drug-naïve patients as well5–10. The cause of this phenomenon and its 
clinical relevance remain poorly understood.
Because alpha rhythm alterations have been reported in such a disparate variety of epilepsy syndromes, they 
might simply reflect an unspecific byproduct of disease. Alternatively, they could point to shared neurobiological 
substrates for seizure generation. Although this might seem counterintuitive, given the multitude of insults and genetic 
mutations that can lead to seizures, a wealth of neuroimaging studies now supports the idea that icto- and epileptogenic 
mechanisms ultimately converge on a set of large-scale neural networks, in which thalamus and midline frontal and 
parietal cortices play an important role, even if they do not contain the seizure focus11. Alpha alterations could therefore 
reflect pathological resting-state dynamics of this core network, and its liability to seizures. In fact, our group has 
previously shown that EEG networks from IGE patients show increased functional connectivity in low alpha 
frequencies12, which associate with an increased propensity to generate seizure-like oscillations13. Does alpha slowing 
therefore indicate that the brain is operating closer to seizure threshold?
To address this question, we quantitatively assessed the distribution of alpha power between high and low 
frequency bands in resting-state EEG recordings of healthy subjects (HS), and FE and IGE patients with good and poor 
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seizure control. We hypothesized that seizure control, but not epilepsy type or AED load, would determine the degree of 
alpha-power shift and its topography, suggesting shared ictogenic mechanisms across epilepsy syndromes.
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METHODS
Participants
We analyzed data from 102 subjects investigated at King’s College Hospital (KCH), London, between 2008 and 2015: 
39 were healthy volunteers recruited through a local volunteer database, and 63 were patients with epilepsy (44 
outpatients and 19 inpatients). Patients were recruited from KCH and collaborating hospitals, and included if they were 
over 18 years of age and had a definite diagnosis of epilepsy made by an experienced epileptologist on the basis of 
clinical presentation, EEG, and MRI. Diagnosis and classification were made in accordance with the International 
League Against Epilepsy (ILAE) 2017 classification of epilepsies and seizures14,15. All controls and 9 IGE patients have 
been included in previous studies12,16.
We divided patients into subgroups based on clinical presentation (IGE versus FE syndromes) and their level of 
seizure control, which we determined from seizure self-reports. This information was corroborated with clinical notes 
and electronic patient records whenever possible. We defined good seizure control (GSC) as fewer than four seizures of 
any type during the 12 months prior to study inclusion, and poor seizure control (PSC) otherwise. We also verified that 
no patient had had a seizure 24hr prior to EEG recording.
This study was approved by the KCH research ethics committee (ref. 08/H0808/157) and the Bromley research 
ethics committee (ref. 12/LO/2030). All participants gave written informed consent before enrolment.
Clinical data
We collected the following variables: gender, age, disease duration, syndrome type and lateralization, seizure types and 
frequency over 12 months, AED number and dosage, total AED load, and the presence of potentially epileptogenic MRI 
lesions. Total AED load was calculated by taking, for each drug, the ratio between its prescribed daily dose, and the 
defined daily dose (as determined by the WHO Collaborating Centre for Drug Statistics Methodology, 
http://www.whocc.no/atc_ddd_index/.) and then summing over all AED17. 
EEG recordings
Ten minutes of awake EEG data were recorded on a NicoletOne system (Viasys Health Care, San Diego, California, 
USA) at 256 Hz from 19 channels positioned according to the international 10–20 system, with two reference electrodes 
attached to the ear lobes. The same EEG technologist performed all healthy subject and outpatient measurements, using 
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the same recording room and system for all participants. Inpatient EEGs were performed by a variety of staff of the 
epilepsy monitoring unit at KCH, according to clinical schedules. If participants consented, hyperventilation and photic 
stimulation were carried out.
EEG visual analysis
Three EEG-trained neurologists (FC, RE and FB) reviewed all EEGs and noted the following phenomena: presence of 
focal interictal epileptiform discharges (IED), generalized spike-wave discharges (GSWD), focal slowing, and normal 
variants. FC, RE and AP then selected two segments of 20 seconds of eyes-closed, awake EEG from each participant for 
subsequent analysis, which had to be free of large movement artefacts, epileptiform discharges, and signs of drowsiness 
or sleep. The first segment was used for the main analyses described below, the second was held out for control analyses. 
Data review and selection were done before data analysis. Further data analysis was carried out by EA, who was not 
involved in selection of EEG segments.
EEG power spectrum
EEG data were processed using Fieldtrip (Version 20171203, http://www.ru.nl/neuroimaging/fieldtrip)18 running on 
MATLAB (R2016b, The MathWorks, Inc., Natick, Massachusetts, United States). EEG segments were first re-
referenced to a common average. We then calculated the power spectra of each segment using a Hanning-tapered fast 
Fourier transform (FFT). To this end, each segment was cut into a series of 1 second epochs with 90% overlap, 
demeaned, multiplied with the Hanning-taper, and zero-padded before computing the FFT. Power was calculated by 
squaring the modulus of the Fourier coefficients for each channel from 2 to 20 Hz in steps 1 Hz, and then normalized 
against total power for each channel. We chose this frequency range because it provided a broad overview of frequency 
bands commonly used in the literature, while avoiding very low frequency drifts and eye movements (<2 Hz), as well as 
muscle artefacts (>20 Hz)19. To test our hypotheses, we focused on the low-alpha (6-9 Hz) and high-alpha band (10-11 
Hz)20. This choice was motivated by band-definitions used in previous work from our group12,13. 
Statistical analysis
Clinical data were analyzed using JASP (Version 0.8.6, https://jasp-stats.org/) or SPSS (Version 24, IBM UK, London). 
We report continuous variables as mean ± SD (range) and binary variables as proportions. We used the Shapiro-Wilk test 
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to assess deviations from normality. If assumptions were met, we compared means using unpaired t-tests, else we applied 
the Mann-Whitney U-test (or the Kruskal-Wallis test in the case of 3 groups). We compared proportions using the  2-
test or Fisher’s exact test if the number of observations in any cell was equal or less than five.
The analysis of EEG power spectra had three aims: first, to confirm that there was a shift in the alpha-power 
spectrum from higher to lower frequencies as previously reported, second, to test whether this effect was driven by 
patients with poor seizure control, over and above syndrome classifications, and third, to assess whether the alpha-power 
shift occurred not only over occipital electrodes, where the alpha rhythm usually predominates, but over frontal 
electrodes as well. To simplify calculations, we defined the “alpha-power shift” as our outcome variable, i.e. the ratio of 
average power in the low-alpha power (6-9 Hz) over average power in the high-alpha (10-11 Hz):
𝐴𝑙𝑝ℎ𝑎 ― 𝑝𝑜𝑤𝑒𝑟 𝑠ℎ𝑖𝑓𝑡 =  𝜇𝐿𝑜𝑤 ― 𝑎𝑙𝑝ℎ𝑎 𝑝𝑜𝑤𝑒𝑟𝜇𝐻𝑖𝑔ℎ ― 𝑎𝑙𝑝ℎ𝑎 𝑝𝑜𝑤𝑒𝑟
This measure increases if power in low-alpha frequencies increases, and will decrease otherwise. Collapsing over 
multiple frequencies and using a ratio has the advantage of reducing the number of multiple comparisons. 
We performed all analyses both on grand-average power spectra and on scalp topographies. For the grand-
average analyses, we averaged the power spectra across all channels and then calculated the power shift as above. This 
yielded one value per subject, i.e. a measure of global alpha-power shift without topographical information. Statistical 
analysis was then carried out in JASP statistical software using these values as dependent variable. We first computed a 
one-way between-subjects ANCOVA to test for differences in alpha-power shift between groups, with age and gender 
serving as covariates (which were included because of their known effects on EEG power spectra)21. Other clinical 
covariates were omitted because they were confounded with group assignment (i.e. only patients were treated with 
AEDs), and thus would have reduced model degrees of freedom without explaining clinically meaningful differences. 
We assessed the equality of variances using Levene’s test, and the assumption of the homogeneity of regression slopes 
by modelling interaction terms between the group variable and each covariate. Furthermore, we inspected Q-Q plots of 
residuals to assess their departure from normality. We then used an F-test to determine the main effect of group, and 
post-hoc t-tests to assess the difference between the three subgroups. We next conducted a 2 x 2 between-subjects 
factorial ANCOVA on the patient data only, with the first factor syndrome (FE or IGE) and the second factor seizure 
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control (GSC or PSC), with age, gender and total AED load serving as covariates. AED load has been shown to increase 
low frequency power in previous patient studies5,22; it was thus essential to include it as a covariate in here. Assumptions 
checks and statistical tests were conducted as above. We used a significance threshold of p <.05, family-wise error 
(FWE) corrected for multiple comparisons (Bonferroni).
For the topographic analyses, we calculated the alpha-power shift for each channel individually, and then 
linearly interpolated these values to produce, for each subject, a 2D scalp map on a regular 32 x 32 mm spatial grid23. 
Maps were then smoothed with an 8 x 8 mm2 Gaussian kernel to account for the relatively sparse spatial sampling23. 
Statistics on these maps were carried out with Permutation Analysis of Linear Models (PALM, version alpha109, 
https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/PALM)24. We calculated pair-wise comparisons between (1) healthy subjects and all 
patients, (2) GSC and PSC patients, and (3) IGE and FE patients, using unequal variances t-test at each map element (or 
voxel), with age and gender serving as covariates for all models, and AED load as an additional covariate for between-
patient comparisons. This yielded one T-map per comparison (we did not recalculate the F-tests on spatial maps to avoid 
redundancy). To assess statistical significance without distributional assumptions, we ran permutations tests, i.e. 
recalculated T-maps after shuffling subjects between groups, using the Freedman-Lane algorithm to account for the 
presence of covariates (10’000 permutations)24. We set the significance threshold at p<.05, FWE-corrected based on the 
empirical t-value distribution derived from permutations. 
To quantify effect sizes, we derived 2 and Hedge’s g for all F- and t-tests, respectively. Hedge’s g has the same 
interpretation as Cohen’s d, but is less biased in the presence of unequal sample sizes25. We used 2 as provided from 
JASP output, and calculated Hedge’s g using the Measure of Effect Size toolbox 
(https://github.com/hhentschke/measures-of-effect-size-toolbox). 
Control analyses
We conducted a number of control analyses to rule out confounds (see supplemental materials). These included (1) 
repeating the analyses above using individual alpha frequency (IAF) instead of alpha-power shift, (2) assessing whether 
comparable effects could be reproduced in a second data segment of the same EEG recording, (3) testing two alterative 
seizure-control stratifications, i.e. grouping patients according to whether they had no versus any seizures and according 
to a median split, (4) testing a direct correlation between seizure frequency and alpha-power shift, without subgroup 
dichotomization, (5) investigating circadian influences by comparing EEG recording times between groups, (6) checking 
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for potential effects of specific AEDs, if their load varied between groups, and (7) repeating the topographical analysis in 
non-lesional epilepsy syndromes to rule out that spatial alterations were an epiphenomenon of structural damage.
 
Classification analysis
Post hoc, we also explored whether alpha-power shifts could be used to predict subject-wise seizure control and used a 
10-fold cross-validated linear discriminant analysis (LDA) to classify GSC and PSC patient data26.
Data visualizations and resources
Plots of average spectra were generated with Gramm27, high-resolution scalp topographies with SPM12 and Fieldtrip. 
Code and processed data are publicly available on https://osf.io/f2vya/. Raw EEG data can be obtained from the senior 
author upon request.
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RESULTS
Clinical features
Table 1 summarises clinical data. There were more patients with a focal syndrome in the PSC compared to the GSC 
group. In keeping with this finding, PSC patients suffered more often from focal impaired awareness seizures, presented 
more focal IED, and more often MRI lesions. On the other hand, GSC patients were treated on average with higher doses 
of Lamotrigine compared to PSC patients. Photic stimulation and hyperventilation were performed only in a subset of 
patients and were inconspicuous in all of them (photic: 15 GSC, 14 PSC; hyperventilation: 12 GSC, 13 PSC).
Alpha-power shifts occur in patients with poor seizure control in both focal and generalized epilepsy syndromes, and 
do not depend on age, gender, or drug load
Visual inspection of average power spectra revealed a shift of EEG power from high- to low-alpha in all subgroup 
comparisons (Fig. 1A-C). To quantify these observations, we first calculated a one-way between-subjects ANCOVA 
comparing HS against both PSC and GSC, with age and gender serving as covariates. Levene’s test was significant 
(p<.001); this was ameliorated after taking the binary log of the alpha-power shift (p = .268). Q-Q-plot of residuals 
showed no departure from normality, and tests for the assumption of homogeneity of regression slopes revealed no 
interaction between covariates and groups (gender x group, p =.307, age x group, p = .520), indicating that model 
assumptions were met. After partialling out variance associated with age and gender, there was a statistically significant 
difference in alpha-power shift between groups, F(2,97) = 17.20, p <.001, 2 = 0.26. Planned contrasts revealed that 
patients presented a clear alpha-power shift compared to HS (M = -0.32, SD = 0.48), t(100) = 3.62, p <.001, g = 0.78, 
95% CI [0.43,1.20]. This effect was driven by PSC patients (M = 0.28, SD = 0.48), which had a substantially larger shift 
than the GSC group (M = -0.24, SD = 0.41), t(61) = 4.23, p <.001, g = 1.14, 95%CI [0.65,1.74] (Fig. 1D). 
We next assessed whether alpha-power shifts were a unique feature of PSC patients, regardless of the 
underlying syndrome. To do so, we conducted a 2 x 2 between-subjects factorial ANCOVA with the first factor 
syndrome (FE or IGE) and the second factor seizure control (GSC or PSC), with age, gender and total AED load serving 
as covariates. Again, tests for homogeneity of variances and regression slopes were not significant (all p > .05). We 
found statistically significant main effects of syndrome, F(1,59) = 7.74, p =.007, 2 = 0.099, and seizure control, F(1,57) 
= 11.65, p =.001, 2 = 0.15, but no statistically significant interaction, F(1,57) = 0.477, p = .492, 2 = 0.006. Planned 
contrasts indicated that FE patients (M = 0.27, SD = 0.48) presented a larger alpha-power shift than IGE patients (M = -
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0.20, SD = 0.45), t(61) = 2.78, p =.007, g = 1.16 [95%CI 0.67,1.74]. Within each syndrome category, PSC patients 
showed significantly larger shifts than their GSC counterparts, t(61) = 3.41, p = .001, g = 1.12 [95%CI 0.64,1.70] (Fig. 
1E). 
Alpha-power shifts are topographically extended, indicating a forward spread of low-alpha power
We next asked whether there was a topographical shift, i.e. a forward spread of the low-frequency alpha rhythm, as well. 
To do so, we calculated pairwise comparisons between groups using topographical maps of alpha-power shift and 
assessed their significance with permutation tests.
This analysis revealed that alpha-power was shifted in patients towards lower frequencies both frontally and 
occipitally, with a maximum over the right occipital region (Table 2, Fig. 2A). Again, this effect was driven by PSC 
patients, who presented an increased alpha-power shift that broadly covered the entire scalp, with peaks over central and 
bilateral occipital regions (Table 2, Fig. 2B). The comparison between IGE and FE patients revealed that FE patients had 
more alpha-power shift over both frontal regions, with a maximum on the right (Table 2, Fig. 2C). 
Control analyses confirm a general slowing down of the alpha-rhythm, and rule out data selection or acquisition 
biases as alternative explanations
We conducted a number of control analyses to test the robustness of our findings to methodological choices. Full results 
are summarised in the supplemental materials. Briefly, comparing patients on the basis of IAF instead of power lead to 
qualitatively similar results, as did analysing a second data segment from the same recording. Furthermore, PSC patients 
were always more shifted compared to GSC patients, even when using alternative dichotomisation rules or accounting 
for patients on lamotrigine (which showed between-group dosage differences). Of note, we also found a significant 
correlation between individual alpha-power shift and seizure frequency, particularly over frontal recording sites, thus 
corroborating the subgroup analyses above. In addition, there were no significant differences in terms of EEG recording 
times, ruling out circadian confounds. Finally, both focal PSC patients without discernible brain lesions, as well as IGE-
PSC patients, which are non-lesional per definition, showed anteriorisation of low alpha-power. 
These analyses thus show that findings were fairly consistent over a number of approaches, and robust to 
confounds.
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Alpha-power shift can discriminate seizure control subgroups
An exploratory LDA with 10-fold cross-validation achieved the following performance parameters (mean ± SD [95% 
CI]): sensitivity of 71.2±3.9% [63.5%, 78.8%], specificity of 79.6±2.2% [75.2%, 83.9%], and AUC of 78.8±1.0% 
[67.7%, 89.8%], which was highly significant (z-test, p = 1.7 * 10-7). 
DISCUSSION
In this study, we show that the power spectrum of the alpha rhythm is shifted towards lower frequencies in 
epilepsy patients with poor seizure control, in both focal and generalized epilepsy syndromes. Furthermore, we 
demonstrate that this effect extends from occipital to frontal regions, and is more pronounced in FE patients. Our study 
took major steps to control for methodological confounds. Firstly, we explicitly included age, gender and AED load as 
covariates in all our models, and used permutation-based statistics for assessing scalp EEG topographies, thus achieving 
adequate false-positive control with few assumptions. Secondly, we confirmed that our results were robust to data 
selection procedures, patient subgroup definitions, circadian effects, and different outcome metrics (power versus 
frequency). Finally, we could show that spatial alterations in alpha-power occurred also in non-lesional epilepsy 
syndromes. Taken together, the present analyses indicate that space-frequency alterations of the alpha rhythm strongly 
associate with increased seizure liability in common epilepsy syndromes, whether generalized or focal.
The observation that alpha rhythm is altered in epilepsy is not new. In fact, a number of historic and 
contemporaneous studies have described slower alpha rhythms in heterogeneous (focal and generalized) epilepsy 
cohorts, sometimes pointing out the anteriorisation of topography as well3–6,8. Capitalising on recent advances in 
permutation statistics and topographical EEG analysis23,24, our study advances this line of research by showing that this 
seemingly ubiquitous phenomenon is likely related to seizure liability: significant alpha-power shifts were present in all 
patients when compared to healthy controls, but were specifically driven by patients with poor seizure control. Effect 
sizes were moderate to very large, indicating that these findings were not subtle in quantitative terms. Importantly, 
analyses were done on data segments that were considered normal by experts, suggesting that on-going background EEG 
rhythms contain clinically valuable information that cannot be gleaned from visual analysis alone. This information that 
could have practical utility: a post-hoc, exploratory classification analysis suggests that patients with poor versus good 
seizure-control might be identified at the individual level with fair accuracy (AUC ~0.8) on the basis of alpha-power 
shifts alone. This performance is comparable to a recent report that used highly optimised classifiers on resting-state 
Page 12 of 35Annals of Clinical and Translational Neurology
PAGE 13
EEG data to discriminate between epilepsy patients and neurological controls5, although larger, multi-center data sets are 
certainly needed to confirm this result. 
Another important aspect is that alpha-power shifts were present in equal measure both in FE and IGE 
syndromes, i.e., there was no significant syndrome-by-seizure control interaction (parallel slopes in Fig 1E). This means 
that, independent of the underlying clinical syndrome, patients with poor seizure control exhibit more alpha-slowing and 
frontal spread than well-controlled patients, although power in FE patients was more shifted overall (Fig. 1E), and there 
were clear topographic differences of this effect between IGE and FE patients (Fig. 2C). These findings suggest that 
alpha-rhythm alterations might reflect seizure-promoting mechanisms that are generic to all common epilepsy types, but 
additionally undergo syndrome-specific modulation.
The neurobiological basis of these observations is at present unclear, but could relate to the underlying severity 
and extent of cortical dysfunction. Evidence from different lines of research gives strength to the idea that there are 
indeed generic disease mechanisms or processes that cut across epilepsy phenotypes, and that might affect oscillatory 
EEG features. For instance, it is well-known from clinical experience that multiple pathologies lead to similar seizure 
behavior, a phenomenon which can be explained by the involvement of large-scale networks11. Indeed, a recent MRI 
study has shown that common epilepsy syndromes share structural abnormalities most prominently in right thalamus and 
precentral gyri28, and an overview of recent neuroimaging studies suggest that medial frontal cortices are key nodes in 
epilepsy-related networks as well29. Interestingly, the topographies of alpha-power shift we uncovered in PSC patients 
are broadly reminiscent of those associated with mid-frontal theta oscillations (4-7 Hz) seen during cognitive tasks; these 
are commonly thought to arise from medial frontal cortices30. Recent results from intracranial EEG suggest that the alpha 
rhythm is generated by anterior (“higher-order”) cortices and then travels posteriorly in a wave-like fashion, driving 
thalamic alpha-rhythm as well1. With this background in mind, one might therefore hypothesize that alpha-power shifts 
might reflect dysfunction of a large-scale cortico-thalamic network that includes frontal cortex, and that disruption of this 
circuitry might be the common final pathway that links disparate clinical syndromes. This hypothesis could be tested 
with concurrent EEG-fMRI data, or by correlating EEG data with MRI-based cortex morphometry. Whether alpha-
power shifts are indeed causally involved in seizure liability could be further assessed in longitudinal studies: our results 
would predict that the alpha rhythm should shift back to normal frequency and configuration after treatment initiation, 
and that this effect might depend on the degree of underlying structural compromise.
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Limitations of this study include its heterogenous in- and outpatient sample, and its reliance on seizure self-
reports, which probably underestimate seizure occurrence. Barring invasive long-term recordings31, there is currently no 
other reliable approach to assess the ground truth of seizure frequency in any single patient. Scalp video-telemetry, 
particularly at home, might offer a solution, but seizure rates in this context will likely depend on a number of 
circumstantial factors, e.g. timing and tempo of AED weaning, and recording length. On the other hand, we note that we 
found a direct correlation between seizure frequency and alpha-power shifts (see supplemental materials). This indicates 
that, despite the shortcomings of seizure self-reports, our approach was sensitive enough to capture meaningful 
(continuous) variability between individual seizure load and alpha-rhythm abnormalities.  Another concern is that our 
study had less power to detect interactions between syndrome type and levels of seizure control, given the low number of 
patients in each subgroup. However, we note effects for the different subgroup contrasts were large compared to the 
interaction contrast, which had an exceedingly low effect size (2 = 0.006). It seems therefore unlikely that we missed an 
interaction in the present data set. Finally, excessive daytime sleepiness is a well-known phenomenon in patients with 
epilepsy32, and sleep homeostasis might be particularly disrupted in drug-resistant patients33. Since we did not assess 
sleepiness explicitly, it cannot be definitively ruled out, and we think it should be recorded systematically in future 
studies (e.g. with patient questionnaires). Even so, given that our analyses ruled out circadian differences in EEG 
recordings, and the fact that experienced neurophysiologists selected the analyzed EEG segments, it seems highly 
unlikely that sleepiness played a major role in our data. 
In sum, we show that the resting-state human alpha rhythm is slower and extends frontally in patients with 
epilepsy, a phenomenon that we were able to link to seizure control across clinical syndrome boundaries. While the 
pathophysiology of such resting-state alterations remains to be explored34, we hypothesize that this effect could be 
commensurate with the degree of cortico-thalamic dysfunction. This type of analysis could therefore provide a gateway 
to understand the pathophysiology of epilepsy or to develop epilepsy biomarkers that does not depend on the recording 
of epileptiform signals.
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FIGURE LEGENDS
Figure 1. Alpha power is shifted towards lower frequencies in patients with poor seizure control across clinical 
syndromes. The three plots in the upper row (A-C) compare the following pairs of power spectra (from left to right): 
patients versus healthy subjects, patients with poor- versus good seizure control, and patients with focal versus idiopathic 
generalized epilepsy. Lines indicate group averages and shaded areas 95% confidence intervals (CI). Tick marks and 
black lines above the x-axis show frequencies at which power spectra diverge: a shift towards lower alpha frequencies 
can be appreciated for the whole patient cohort, for poor seizure control, and for focal epilepsy subgroups. Plots D and E 
show the statistical assessment of this observations in terms of the (log-transformed) alpha-power shift, i.e. the ratio of 
average low- to average high alpha-power. Higher values indicate more low-alpha power. Dots and error bars represent 
means ± 95% CI. P-values are derived from pair-wise contrasts of two analyses of covariance (see Methods for details). 
There was a significant difference between healthy subjects and patients, which was driven by poor seizure control 
patients (p<.001, panel D). The power spectrum of focal epilepsy patients was more shifted than the power spectrum of 
idiopathic generalized epilepsy patients (p=.007, Panel E, horizontal line). However, there was no syndrome-by-seizure 
control interaction: alpha power in poor seizure control patients was always more shifted than alpha power in GSC 
patients (p=.001), and this occurred in equal measure in both syndrome categories (Panel E, vertical line).
Figure 2. Alpha-power shifts are topographically extended, indicating a forward spread of low-alpha power. This 
figure shows topographical maps for three pair-wise comparisons: panel (A), healthy subjects versus all epilepsy 
patients, panel (B), good-seizure control versus poor-seizure control patients, and panel (C), idiopathic generalized 
epilepsy versus focal epilepsy patients. The first two columns on the left show raw data: positive values (red) indicate a 
shift of EEG power towards the low-alpha band, negative (blue) values a shift towards the high alpha band. The third and 
fourth column show statistical maps, i.e. p-values and effect sizes, respectively. Maps of family-wise error (FWE) 
corrected p-values were derived using permutation tests. White areas did not reach the significance threshold. The last 
column shows effect size maps (Hedges’ g), where g = 0.2 represents a weak, and g = 1.3 a very large effect. Note that 
all patients present significant shifts of alpha power compared to healthy controls over the entire scalp (panel A), with 
large effects occipitally, and that this effect is particularly pronounced in poor seizure control patients: very large effects 
are seen here over bilateral and midline frontal regions (panel B). Finally, t focal epilepsy patients had more frontal 
alpha-power shift, i.e. more low-alpha power, over frontal regions compared to idiopathic generalized epilepsy patients, 
(panel C). 
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TABLES
Table 1. Demographic and clinical characteristics in healthy subjects (HS), epilepsy patients with good seizure control (GSC), and epilepsy patients with poor seizure 
control (PSC)
HS (n = 39) GSC (n = 25) PSC (n = 38) Statistic p
Female sex, n (%) 19 (49) 15 (60) 19 (50) 2(2, 102) = 0.87 .647
Age, y 30  9 (18 - 53) 33  12 (20 - 77) 38  14 (20 - 68) H = 4.62 .099
Disease characteristics
Disease duration, y - 16  10 (1 - 42) 17  15 (2 - 58) U = 424.5 .482
FE syndrome, n (%) - 10 (40) 27 (71) 2(1, 63) = 6.00 .014
FE left lateralized, n (%) - 5 (20)* 14 (37)* Fisher’s exact test .175
FE right lateralized, n (%) 3 (12) 12 (32) Fisher’s exact test .129
GTCS, n (%) - 4 (16) 12 (32) Fisher’s exact test .233
AS, n (%) - 4 (16) 4 (11) Fisher’s exact test .394
FIAS, n (%) - 1 (4) 24 (62) Fisher’s exact test <.001
FAS, n (%) - 0 (0) 2 (5) Fisher’s exact test .513
EEG characteristics
Background slowing, n (%) - 1 (4) 3 (8) Fisher’s exact test .999
Focal slowing, n (%) - 4 (16) 15 (39) Fisher’s exact test .055
GSWD, n (%) - 5 (25) 10 (26) Fisher’s exact test .764
IED, n (%) - 4 (19) 15 (39) Fisher’s exact test .002
MRI characteristics†
Lesion, n (%) - 3 (14) 17 (50) Fisher’s exact test .005
MTS, n (%) - 2 (8) 6 (16) Fisher’s exact test .246
Medication
AED, n - 1 (1 - 3)¶ 2 (2 - 3) U = 375.9 .119
AED drug load, a. u. - 1.4  0.9 (0.4 - 4.3) 1.5  0.8 (0.2 - 4.0) U = 417.0 .418
Patients on LTG, n (%) - 10 (40) 12 (32) Fisher’s exact test .802
LTG dosage, mg - 350 ± 91 (200 - 450) 242 ± 120 (50 - 400) t(20) = 2.3‡ .030
Patients on LEV, n (%) - 7 (28) 11 (29) Fisher’s exact test .999
LEV dosage, mg - 1500 ± 595 (750 - 2500) 1550 ± 934 (300 - 3000) t(16) = -0.13 .902
Patients on VPA, n (%) - 8 (32) 10 (26) Fisher’s exact test .789
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VPA dosage, mg - 838 ± 307 (300 - 1200) 1000 ± 531 (300 - 2000) t(16) = -0.77 .455
Patients on CBZ, n (%) - 6 (24) 10 (26) Fisher’s exact test .999
CBZ dosage, mg - 833 ± 497 (400 - 1400) 690 ± 277 (200 - 1000) U = 35.0 .618
Others, n - 2 ETX, 1 LAC, 1 TGB, 1 TPM, 1 ZNS 2 LAC, 1 OXC, 3 PHT, 1 TGB, 6 TPM, 2 ZNS - -
Abbreviations: AED, antiepileptic drugs, a. u., arbitrary units; AS, absence seizures, F/M, female/male; FAS, focal aware seizures; FE, focal epilepsy; FIAS, focal impaired 
awareness seizures ; GTCS, generalized tonic-clonic seizures; GSWD, generalized spike-wave discharges; H, Kruskal-Wallis tests; IED, interictal epileptiform discharges; IGE, 
idiopathic generalized epilepsy; MTS, mesial temporal lobe sclerosis; MRI, magnetic resonance imaging;  n, number; t-test (degrees of freedom); U, Mann-Whitney-U-test; 2, 
Chi-square test (degrees of freedom, sample size); y, years. AED names: CBZ, carbamazepine; ETX, ethosuximide; LAC, lacosamide; LEV, levetiracetam; LTG, lamotrigine; 
OXC, oxcarbazepine; PHT, phenytoin; TGB, tiagabine; TPM, topiramate; VPA, valproic acid; ZNS, zonisamide. Notes: numbers are given as mean  SD (range), unless stated 
otherwise, and all p-values are two-tailed. (*) Lateralization was unclear for 2 GSC and 1 PSC patient with FE. (†) MRI reports were not available in 1 patient with good, and 4 
patients with poor seizure control. (‡) T-tests where used if data met normality assumptions, U-tests otherwise. (¶) Median (range). 
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Table 2. Statistical results for alpha-power shift topographies
Factors Covariates Contrast Peak statistic (df) p(FWE)*
Effect size g 
[95% CI]†
Nearest 
electrode
Group (healthy subjects, GSC patients, 
PSC patients) Age, Gender PAT > HS t(97) = 4.52 <.001 1.03 [0.65, 1.47] T6
Seizure control (GSC, PSC) Age, Gender, AED load PSC > GSC t(56) = 4.31 < .001 1.28 [0.86, 1.80] C3
Syndrome (IGE, FE) Age, Gender, AED load IGE < FE t(56) = 2.72 .031 -1.15 [-0.65, -1.81| O1
Abbreviations: AED, antiepileptic drugs; CI, confidence interval; df, degrees of freedom; FE, focal epilepsy; GSC, good seizure control; HS, healthy subjects; 
IGE, idiopathic generalized epilepsies; n. s., not significant; PAT, all patients; PSC, poor seizure control. Notes: Electrode names follow the standard 10-20 
system. (*) p-values have been family-wise error (FWE) corrected using Gaussian random fields. (†) Effect size measure based on mean differences divided by 
the pooled and weighted standard deviation. Interpretation: 0.2 = small, 0.5 = medium; 0.8 = large, 1.2 = very large effect. Confidence intervals were derived 
from 5000 bootstrap samples
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1Supplemental Materials
Content
This document describes supplementary analyses to Abela, Pawley et al., “Slower alpha rhythm associates with poorer 
seizure control in epilepsy”. The order of analyses is as follows:
Analysis 1 Re-analysis using individual alpha frequencies (IAF) instead of alpha-power shift.
Analysis 2 Test of reproducibility using a second segment of EEG data.
Analysis 3 Assessment of two alternative seizure-control definitions, i.e. 
(a) Good seizure control: no seizures versus poor seizure control: any seizures,
(b) Good seizure control: below median of seizure frequency versus poor seizure control: 
above median of seizure frequency.
Analysis 4 Correlation analysis using a continuous measure of seizure frequency
Analysis 5 Comparing EEG recording times across groups to assess potential circadian effects
Analysis 6 Additional control for anti-epileptic drug (AED) effects.
Analysis 7 Topographic analysis to rule out lesional effects on spatial alpha-power shifts
All statistical analyses were done in JASP (Version 0.8.6, https://jasp-stats.org/), if not noted otherwise. Links point to 
extended results on the Open Science Framework (www.osf.io).
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2Analysis 1: Re-analysis using individual alpha frequencies (IAF) instead of alpha-power shift.
Rationale and method
We sought to confirm that alpha-power shifts were indeed accompanied by a deceleration of the individual alpha 
frequency (IAF). Because we calculated the alpha-power shift as a ratio between fixed frequency bands, a significant 
shift could occur due to redistribution of power between bands, without actual slowing of the peak individual alpha 
rhythm. We thus found the IAF as the frequency of maximum power in the extended alpha-band (6-13Hz), and compared 
individual log-transformed IAF between patient groups, using the same ANCOVA model described in the main 
manuscript. Our hypothesis was that, as in the main analysis, IAF would differ between seizure-control groups, but that 
there would not be an interaction between syndrome type (focal versus generalised) and seizure control. 
Results (Link: https://osf.io/739qr/)
ANCOVA - IAF (log) 
Cases Sum of Squares df Mean Square F p 
Seizure control 0.037 1.000 0.037 7.283 0.009 
Syndrome 0.016 1.000 0.016 3.052 0.086 
Seizure control ✻ Syndrome 2.352e -4 1.000 2.352e -4 0.046 0.831 
Gender 0.005 1.000 0.005 1.067 0.306 
Age 6.955e -5 1.000 6.955e -5 0.014 0.907 
AED Load 0.001 1.000 0.001 0.285 0.596 
Residual 0.286 56.000 0.005   
Note.  Type III Sum of Squares 
Post Hoc Comparisons - Seizure control 
    Mean Difference SE t p bonf 
GSC PSC 0.053 0.020 2.699 0.009 
 
Post Hoc Comparisons - Syndrome 
    Mean Difference SE t p bonf 
FE IGE -0.035 0.020 -1.747 0.086 
Conclusion
This analysis confirms that the alpha rhythm is indeed slower between seizure control groups. In contrast to the main 
analysis, there is no difference between FE and IGE, supporting the idea that slower alpha rhythm in epilepsy is 
syndrome-independent.
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3Analysis 2: Test of reproducibility using a second segment of EEG data.
Rationale and method
We assessed whether results differed between data segments. We thus repeated alpha-power shift comparisons for the 
average power spectra on a second data segment, which was available in 57/63 patients (missing in six because of 
considerable artefacts throughout the recording: 2 IGE, each in the GSC and PSC group, and 4 FE, 1 in the GSC and 3 in 
the PSC group). We applied the same ANCOVA model described in the main text.
Results (Link: https://osf.io/739qr/)
ANCOVA - Alpha-power shift (log) second segment 
Cases Sum of Squares df Mean Square F p 
Seizure control 1.702 1.000 1.702 9.903 0.003 
Syndrome 0.947 1.000 0.947 5.508 0.023 
Syndrome ✻ Seizure control 0.277 1.000 0.277 1.609 0.210 
Gender 0.351 1.000 0.351 2.044 0.159 
Age 0.007 1.000 0.007 0.042 0.839 
AED Load 0.602 1.000 0.602 3.503 0.067 
Residual 8.596 50.000 0.172   
Note.  Type III Sum of Squares 
Post Hoc Comparisons - Seizure control 
    Mean Difference SE t Cohen's d p bonf 
GSC PSC -0.381 0.121 -3.147 -0.852 0.003 
Note.  Cohen's d does not correct for multiple comparisons. 
Post Hoc Comparisons - Syndrome 
    Mean Difference SE t Cohen's d p bonf 
FE IGE 0.287 0.122 2.347 0.633 0.023 
Note.  Cohen's d does not correct for multiple comparisons. 
Conclusion
This analysis confirms that alpha-power is shifted towards lower frequencies in a second data set from the same 
recording, and thus reproducible within one recording session.
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4Analysis 3: Assessment of two alternative seizure-control definitions 
Rationale and method 
Because we used a heuristic for dividing patients into seizure-control subgroups, there is a concern that group differences 
might be sensitive to the seizure frequency thresholds used. Also, patients that are completely seizure free might differ 
neurobiologically from those with only a few seizures. We therefore tested two alternative seizure control definitions: a 
zero-split (i.e. patients without any seizures versus all others) and a median-split (i.e. patients with seizure frequency 
below versus above the median). We applied the same ANCOVA model described in the main text.
Results (Link: https://osf.io/ch78y/)
ANCOVA - Alpha-power shift (log) / Zero-split
Cases Sum of Squares df Mean Square F p η² 
Seizure control (zero split) 1.471 1.000 1.471 7.441 0.009 0.103 
Syndrome 1.333 1.000 1.333 6.741 0.012 0.093 
Seizure control (zero split) ✻ Syndrome 0.121 1.000 0.121 0.610 0.438 0.008 
Gender 0.015 1.000 0.015 0.074 0.787 0.001 
Age 0.008 1.000 0.008 0.040 0.842 0.001 
AED Load 0.258 1.000 0.258 1.307 0.258 0.018 
Residual 11.072 56.000 0.198     
Note.  Type III Sum of Squares 
Post Hoc Comparisons - Seizure control (Zero split) 
    Mean Difference SE t p bonf 
GSC PSC -0.339 0.124 -2.728 0.009 
 
Post Hoc Comparisons - Syndrome 
    Mean Difference SE t p bonf 
FE IGE 0.325 0.125 2.596 0.012 
(continued on next page)
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5ANCOVA - Alpha-power shift (log) / Median-split
Cases Sum of Squares df Mean Square F p η² 
Seizure control (median split) 1.742 1.000 1.742 8.940 0.004 0.121 
Syndrome 1.450 1.000 1.450 7.438 0.009 0.101 
Seizure control (median split) ✻ Syndrome 5.230e -4 1.000 5.230e -4 0.003 0.959 0.000 
Gender 0.016 1.000 0.016 0.081 0.777 0.001 
Age 0.037 1.000 0.037 0.189 0.665 0.003 
AED Load 0.195 1.000 0.195 1.001 0.321 0.014 
Residual 10.913 56.000 0.195     
Note.  Type III Sum of Squares 
Post Hoc Comparisons - Seizure control (Median split) 
    Mean Difference SE t p bonf 
GSC PSC -0.356 0.119 -2.990 0.004 
Post Hoc Comparisons - Syndrome 
    Mean Difference SE t p bonf 
FE IGE 0.333 0.122 2.727 0.009 
Conclusion
Two alternative seizure-control definitions yield qualitatively similar results to the main analysis, indicating that findings 
are not sensitive to the choice of threshold.
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6Analysis 4: Correlation analysis using a continuous measure of seizure frequency
Rationale and method
All analyses above and in the main manuscript were based on dichotomisation of patient groups based on 
seizure frequency. While results are consistent across three different criteria, they do not reveal the full extent 
of the variability in the data. To gain further insight into the relationship between alpha-rhythm alterations and 
seizure control, we calculated Pearson’s correlation between individual alpha-power shift and self-reported 
seizure frequency across the patient cohort, without dichotomisation, both using channel-averaged and 
topographically-resolved alpha-power shift values. Both measures were log-transformed before correlation. 
An offset of 1 was added to the seizure frequency values before taking the log to avoid zero values. The 
topographical analysis with the same permutation-based methods are described in the main manuscript. 
Results (Link: https://osf.io/npdx9/)
Average alpha-power shift across all channels was positively correlated with individual seizure frequency: 
Person’s correlation coefficient, r = 0.403, p <.001 (Figure, left panel). Using spatial correlations (seizure 
frequency against alpha-power shift at each channel), we found a positive correlation, particularly over frontal 
recording sites (Figure, right panel). 
 
Conclusion
Correlation analysis yields qualitatively similar results to the main subgroup analyses: poorer seizure control 
associates with an increased shift of alpha-power to lower frequencies, particularly over frontal recordings 
sites.
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7Analysis 5: Comparing EEG recording times across groups to assess potential circadian effects.
Rationale and method 
We investigated whether there were systematic differences between subgroups in the time of day at which EEG 
recording was carried out. This was done because it was not possible to record all EEG data during the same time of the 
day, and because there is well-documented interplay between circadian rhythms and seizure liability1,2. To assess this, we 
retrieved the time stamps of each EEG recording from the raw data files, converted them from hours to radians (on a 24-
hr circle) and calculated a Watson-Williams test, which compares means of circular data for two or more groups, 
between GSC and PSC patients (CircStat, https://github.com/circstat/circstat-matlab)3.
Results
Descriptive Statistics
Group Circular Mean (rad.) Circular Standard Deviation (rad.)
GSC -2.7002 0.6427
PSC -2.5939 0.7523
ANOVA-Table (Watson-Williams test)
 d. f. SS MS F p-Value
Columns 1 0.07 0.07 0.30 0.5861 0.5861
Residual 61 15.69 0.26
Total   62 15.75
d. f, degrees of freedom; SS, sum of squares; MS, mean square; F, F-statistic
Conclusion
Analysis of recording times using circular statistics shows no difference in daytime of EEG recordings between seizure 
control groups, thus rendering circadian effects unlikely.
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8Analysis 6: Additional control for anti-epileptic drug (AED) effects.
Rationale and method 
We found that patients with good seizure control (GSC) were treated on average with higher doses of lamotrigine (LTG), 
which has been shown to accelerate alpha frequency, and might therefore reduce the alpha-power shift measure4. To test 
whether different LTG dosages biased between-group differences, we calculated independent samples t-test between (1) 
all GSC patients (n = 10) and poor seizure control (PSC) patients (n = 12) on LTG, (2) GSC patients with (n=10) and 
without (n=15) LTG, and (3) PSC patients with (n = 12) and without (n = 26) LTG. We hypothesised that, if the first 
comparison yielded a difference, but the other two did not, then the difference between groups would likely be driven by 
seizure control, and not by an LTG acceleration effect. Put differently, if LTG were to accelerate alpha rhythms in a 
measurable way in our cohort, one would expect both GSC and PSC patients on LTG to have a lower alpha-power shift 
(i.e. more high alpha-power) than their non-LTG counterparts. For completeness, we also compared alpha-power shifts in 
all patients without LTG (Test 4).
Results (Link: https://osf.io/ruvf6/)
Test 1: all GSC patients on LTG versus all PSC patients on LTG
Group Descriptives 
  Group N Mean SD SE 
AlphaPowerShift(log) GSC 10 -0.160 0.212 0.067 
  PSC 10 0.420 0.577 0.182 
Independent Samples T-Test: all GSC patients on LTG versus all PSC patients on LTG
  Test Statistic df p 
AlphaPowerShift(log) Student -2.984 18.000 0.008 
  Welch -2.984 11.384 0.012 
Test 2: GSC patients on LTG versus GSC patients without LTG
Group Descriptives 
  Group N Mean SD SE 
AlphaPowerShift(log) No 15 -0.300 0.478 0.123 
Yes 10 -0.160 0.212 0.067 
Independent Samples T-Test 
  t df p 
AlphaPowerShift(log) -0.866 23.000 0.395 
Note.  Student's t-test. 
(continued on next page)
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Group Descriptives 
  Group N Mean SD SE 
AlphaPowerShift(log) No 26 0.231 0.432 0.085 
  Yes 12 0.417 0.564 0.163 
Independent Samples T-Test 
  t df p 
AlphaPowerShift(log) -1.118 36.000 0.271 
Note.  Student's t-test. 
Test 4: all GSC patients not on LTG versus all PSC patients not on LTG
Group Descriptives 
  Group N Mean SD SE 
AlphaPowerShift(log) GSC 15 -0.300 0.478 0.123 
  PSC 27 0.222 0.434 0.084 
Independent Samples T-Test 
  t df p 
AlphaPowerShift(log) -3.602 40.00 < .001 
Note.  Student's t-test. 
Conclusion
This set of analyses shows that, while well-controlled patients on LTG had indeed a lower alpha-power shift compared to 
poorly controlled patients on LTG (Test 1), they did not differ on average from their peers without LTG (Test 2). This 
was replicated in the poorly controlled patients as well (Test 3), indicating that LTG did not bias our main results; i.e. 
LTG did not artificially reduce the alpha-power shift and therefore enhance differences between seizure control groups. 
This also confirmed with the last test (Test 4):  patients off-LTG show the same pattern compared to those on-LTG (Test 
1). 
We note that small subject numbers are an important limitation, and we cannot rule out significant LTG effects on alpha 
power in larger or more homogeneous populations (i.e. patients in monotherapy). 
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Analysis 7: Topographic analysis to rule out lesional effects on spatial alpha-power shifts
Rationale and method
We show an anteriorisation of the slow alpha rhythm that is particularly pronounced in patients with focal epilepsies (see 
Figure 2 in the main manuscript). Because this group naturally presents a higher rate of lesional syndromes, the 
anteriorisation could be an epiphenomenon. To rule out this possibility, we calculated spatial permutation-based statistics 
(cf. Methods in main manuscript) in two subgroups without lesions: poorly controlled idiopathic generalised epilepsy 
(IGE, n = 10) and poorly controlled non-lesional focal epilepsy (FE, n=11) patients, both against healthy controls.
Results
The figure below shows scalp topographic maps of family-wise error (FWE)-corrected p-values for two independent-
sample t-tests of alpha-power shift: IGE patients with poor seizure control against healthy controls (left), and non-
lesional FE patients with poor seizure control against healthy controls (right). In both cases, significant effects can be 
seen in frontal regions, although the effect is considerably stronger and has a much wider spatial distribution in FE 
patients.
Conclusion
This analysis shows that anteriorisation of low-frequency alpha-power in poorly controlled patients does not depend on 
the presence of lesions, since both IGE patients (which are per definition non-lesional) and FE patients without 
discernible lesions on neuroimaging show this effect. However, the magnitude of the effect is conspicuously different, 
either due to low statistical power or differing pathophysiological mechanisms, or both.
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